￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
The maximum number of days that Fenelidone (Keshenda) cannot be used continuously and its safety analysis

2026-02-01 22:25:32

Check Details
Possible harms and precautions caused by taking rasagiline (Azila)

2026-02-01 22:25:32

Check Details
Introduction to the drug Platinib (Pujihua) and its application progress in the field of targeted therapy

2026-02-01 22:25:32

Check Details
Analysis of the clinical effects of the combination of capmatinib (Tourad) and osimertinib

2026-02-01 22:25:32

Check Details
One month’s treatment cost of Sotolaxib (AMG 510) and price comparison of different versions

2026-02-01 22:25:32

Check Details
Interpretation of the latest policy on whether adagrasib (Krazati) can be reimbursed and included in the medical insurance directory

2026-02-01 22:25:32

Check Details
Differences in efficacy and indications between larotinib (Vitaika) and entrectinib

2026-02-01 22:25:32

Check Details
Analysis of the mechanism of action and common adverse reactions of seliniso (Silvio)

2026-02-01 22:25:32

Check Details
Vigabatrin (Ocoda) adverse reactions response methods and safe use guidelines

2026-02-01 22:25:32

Check Details
The latest market price and purchasing advice of Mobocertinib

2026-02-01 22:25:32

Check Details
Tepotinib (Tuodekang) adverse reactions management methods and patient care guidelines

2026-02-01 22:25:32

Check Details
Detailed explanation of the indications and contraindications for Regorafenib (Belvango)

2026-02-01 22:25:32

Check Details
Category
相关知识